Nadir Mahmood

Nadir Mahmood

Chief Executive Officer chez Rezo Therapeutics, Inc.

Fortune : 927 239 $ au 31/03/2024

44 ans
Health Technology
Consumer Services
Commercial Services

Profil

Nadir Mahmood is currently the Chief Executive Officer & Director at Rezo Therapeutics, Inc. and also serves as a Director at California Life Sciences Association.
Previously, he worked as the Senior Director-Corporate Development at Second Genome, Inc. from 2011 to 2017, Staff Scientist at Kythera Biopharmaceuticals LLC from 2007 to 2009, and as the Chief Financial & Business Officer at Nkarta, Inc. from 2018 to 2023.
Dr. Mahmood received his undergraduate degree from The University of Texas at Austin and his doctorate from The University of Texas Southwestern Medical Center.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/06/2023 85 776 ( 0,12% ) 927 239 $ 31/03/2024

Postes actifs de Nadir Mahmood

SociétésPosteDébut
Director/Board Member 09/03/2021
Chief Executive Officer 20/09/2023
Tous les postes actifs de Nadir Mahmood

Anciens postes connus de Nadir Mahmood

SociétésPosteFin
NKARTA, INC. Director of Finance/CFO 30/06/2023
Corporate Officer/Principal 01/05/2017
KYTHERA BIOPHARMACEUTICALS INC Corporate Officer/Principal 01/07/2009
Voir l'expérience en détail de Nadir Mahmood

Formation de Nadir Mahmood

The University of Texas at Austin Undergraduate Degree
The University of Texas Southwestern Medical Center Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Nadir Mahmood

Relations

65

Relations au 1er degré

7

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
NKARTA, INC.

Health Technology

Entreprise privées4

Health Technology

Health Technology

Commercial Services

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Nadir Mahmood